» Articles » PMID: 33339372

Whole Body 3.0 T Magnetic Resonance Imaging in Lymphomas: Comparison of Different Sequence Combinations for Staging Hodgkin's and Diffuse Large B Cell Lymphomas

Overview
Journal J Pers Med
Date 2020 Dec 19
PMID 33339372
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

To investigate the diagnostic value of different whole-body magnetic resonance imaging (WB-MRI) protocols for staging Hodgkin and diffuse-large B-cell lymphomas (HL and DLBCL), twenty-two patients (M/F 12/10, median age 32, range 22-87, HL/DLBCL 14/8) underwent baseline WB-MRI and F-2-fluoro-2-deoxy-D-glucose (F-FDG) positron emission tomography (PET) fused with computed tomography (CT) scan F-FDG-PET-CT. The 3.0 T WB-MRI was performed using pre-contrast modified Dixon (mDixon), T2-weighted turbo-spin-echo (TSE), diffusion-weighted-imaging (DWI), dynamic-contrast-enhanced (DCE) liver/spleen, contrast-enhanced (CE) lung MRI and CE whole-body mDixon. WB-MRI scans were divided into: (1) "WB-MRI ": whole-body DWI + in-phase mDixon (2) "WB-MRI ": whole-body T2-TSE (3) "WB-MRI ": whole-body CE mDixon + DCE liver/spleen and CE lung mDixon (4) "WB-MRI All ": the entire protocol. Two radiologists evaluated WB-MRIs at random, independently and then in consensus. Two nuclear-medicine-physicians reviewed F-FDG PET-CT in consensus. An enhanced-reference-standard (ERS) was derived using all available baseline and follow-up imaging. The sensitivity and specificity of WB-MRI protocols for nodal and extra-nodal staging was derived against the ERS. Agreement between the WB-MRI protocols and the ERS for overall staging was assessed using kappa statistic. For consensus WB-MRI, the sensitivity and specificity for nodal staging were 75%, 98% for WB-MRI , 76%, 98% for WB-MRI , 83%, 99% for WB-MRI and 87%, 100% for WB-MRI . The sensitivity and specificity for extra-nodal staging were 67% 100% for WB-MRI , 89%, 100% for WB-MRI , 89%, 100% for WB-MRI and 100%, 100% for the WB-MRI . The consensus WB-MRI read had perfect agreement with the ERS for overall staging [kappa = 1.00 (95% CI: 1.00-1.00)]. The best diagnostic performance is achieved combining all available WB-MRI sequences.

Citing Articles

Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas.

Maccioni F, Alfieri G, Assanto G, Mattone M, Gentiloni Silveri G, Viola F Radiol Med. 2023; 128(5):556-564.

PMID: 37145214 PMC: 10182138. DOI: 10.1007/s11547-023-01622-9.


Evaluating prostate cancer bone metastasis using accelerated whole-body isotropic 3D T1-weighted Dixon MRI with compressed SENSE: a feasibility study.

Liao Z, Liu G, Ming B, Ma C, Fan X, Zhang X Eur Radiol. 2022; 33(3):1719-1728.

PMID: 36269371 DOI: 10.1007/s00330-022-09181-9.


The diagnostic performance of whole-body MRI in the staging of lymphomas in adult patients compared to PET/CT and enhanced reference standard-systematic review and meta-analysis.

Lambert L, Burgetova A, Trneny M, Bircakova B, Molinsky J, Benesova K Quant Imaging Med Surg. 2022; 12(2):1558-1570.

PMID: 35111648 PMC: 8739096. DOI: 10.21037/qims-21-649.

References
1.
Gu J, Chan T, Zhang J, Leung A, Kwong Y, Khong P . Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma. AJR Am J Roentgenol. 2011; 197(3):W384-91. DOI: 10.2214/AJR.10.5692. View

2.
Latifoltojar A, Punwani S, Lopes A, Humphries P, Klusmann M, Menezes L . Whole-body MRI for staging and interim response monitoring in paediatric and adolescent Hodgkin's lymphoma: a comparison with multi-modality reference standard including F-FDG-PET-CT. Eur Radiol. 2018; 29(1):202-212. PMC: 6291431. DOI: 10.1007/s00330-018-5445-8. View

3.
Ganeshalingam S, Koh D . Nodal staging. Cancer Imaging. 2010; 9:104-11. PMC: 2821588. DOI: 10.1102/1470-7330.2009.0017. View

4.
Saito E, Matsuoka J . International comparison of Hodgkin and non-Hodgkin lymphoma incidence. Jpn J Clin Oncol. 2019; 50(1):96-97. DOI: 10.1093/jjco/hyz202. View

5.
Padhani A, Lecouvet F, Tunariu N, Koh D, De Keyzer F, Collins D . METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer. Eur Urol. 2016; 71(1):81-92. PMC: 5176005. DOI: 10.1016/j.eururo.2016.05.033. View